Spis treści:
Spis załączników:
Sopharma_monthly_April_2013.doc (REPORT)
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
Sopharma_monthly_April_2013.doc (REPORT)
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 58 | / | 2013 | ||||||||
| Date of issue: | 2013-05-08 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Sopharma monthly April 2013 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych |
|||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD (the “Company") notifies that for April 2013 Sopharma AD realized same level of sales revenues compared to the same period of 2012, including 3% increase of domestic sales and 1% decrease of export sales. During the past four months Sopharma AD recorded a decrease of sales revenues of 3%, including 4% increase of domestic sales and 6% decrease of export sales compared to 2012. |
|||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Sopharma monthly April 2013.docSopharma monthly April 2013.doc | Sopharma monthly April 2013 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) |
||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2013-05-08 | Ognian Donev | Executive director | |||